P2.03a-030 nab-Paclitaxel/Carboplatin Induction Therapy in Squamous (SCC) NSCLC: Interim Quality of Life (QoL) Results From ABOUND.sqm: Topic: Clinical Trials

Michael Thomas; Ray Page; Laurent Gressot; Davey Daniel; Daniel Morgensztern; Victoria Villaflor; Santiago Aix; Teng Ong; Nataliya Trunova; David Spigel

doi:10.1016/J.JTHO.2016.11.1239

P2.03a-030 nab-Paclitaxel/Carboplatin Induction Therapy in Squamous (SCC) NSCLC: Interim Quality of Life (QoL) Results From ABOUND.sqm: Topic: Clinical Trials

Michael Thomas
, Ray Page
, Laurent Gressot
, Davey Daniel
, Daniel Morgensztern
, Victoria Villaflor
, Santiago Aix
, Teng Ong
, Nataliya Trunova
, David Spigel

University Hospital Heidelberg
The Center for Cancer and Blood Disorders, Fort Worth/TX/United States of America
North Cypress Cancer Center, Cypress/TX/United States of America
Tennessee Oncology, Chattanooga/TN/United States of America
Washington University in St. Louis
University of Chicago
Unidad de Investigación Clínica de Cáncer Pulmón H12O-CNIO, Madrid/Spain
Celgene
Sarah Cannon Research Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Thoracic Oncology
Volume	12
Issue number	1
DOIs	https://doi.org/10.1016/J.JTHO.2016.11.1239
State	Published - Jan 1 2017
Externally published	Yes

Disciplines

Medicine and Health Sciences
Oncology
Internal Medicine

Access to Document

10.1016/J.JTHO.2016.11.1239License: Unspecified

Cite this

Thomas, M., Page, R., Gressot, L., Daniel, D., Morgensztern, D., Villaflor, V., Aix, S., Ong, T., Trunova, N., & Spigel, D. (2017). P2.03a-030 nab-Paclitaxel/Carboplatin Induction Therapy in Squamous (SCC) NSCLC: Interim Quality of Life (QoL) Results From ABOUND.sqm: Topic: Clinical Trials. Journal of Thoracic Oncology, 12(1). https://doi.org/10.1016/J.JTHO.2016.11.1239

Thomas, M, Page, R, Gressot, L, Daniel, D, Morgensztern, D, Villaflor, V, Aix, S, Ong, T, Trunova, N & Spigel, D 2017, 'P2.03a-030 nab-Paclitaxel/Carboplatin Induction Therapy in Squamous (SCC) NSCLC: Interim Quality of Life (QoL) Results From ABOUND.sqm: Topic: Clinical Trials', Journal of Thoracic Oncology, vol. 12, no. 1. https://doi.org/10.1016/J.JTHO.2016.11.1239

@article{6d6124b2bf754a408468d9a2877c57e5,

title = "P2.03a-030 nab-Paclitaxel/Carboplatin Induction Therapy in Squamous (SCC) NSCLC: Interim Quality of Life (QoL) Results From ABOUND.sqm: Topic: Clinical Trials",

author = "Michael Thomas and Ray Page and Laurent Gressot and Davey Daniel and Daniel Morgensztern and Victoria Villaflor and Santiago Aix and Teng Ong and Nataliya Trunova and David Spigel",

note = "Despite a high symptom burden in many patients with advanced NSCLC, limited data exist on QoL with first-line chemotherapy. Here we report results of an interim QoL analysis in patients with SCC NSCLC treated with nab-paclitaxel/carboplatin in the induction part of the ongoing ABOUND.sqm study.",

year = "2017",

month = jan,

day = "1",

doi = "10.1016/J.JTHO.2016.11.1239",

language = "American English",

volume = "12",

journal = "Journal of Thoracic Oncology",

number = "1",

}

TY - JOUR

T1 - P2.03a-030 nab-Paclitaxel/Carboplatin Induction Therapy in Squamous (SCC) NSCLC: Interim Quality of Life (QoL) Results From ABOUND.sqm: Topic: Clinical Trials

AU - Thomas, Michael

AU - Page, Ray

AU - Gressot, Laurent

AU - Daniel, Davey

AU - Morgensztern, Daniel

AU - Villaflor, Victoria

AU - Aix, Santiago

AU - Ong, Teng

AU - Trunova, Nataliya

AU - Spigel, David

N1 - Despite a high symptom burden in many patients with advanced NSCLC, limited data exist on QoL with first-line chemotherapy. Here we report results of an interim QoL analysis in patients with SCC NSCLC treated with nab-paclitaxel/carboplatin in the induction part of the ongoing ABOUND.sqm study.

PY - 2017/1/1

Y1 - 2017/1/1

UR - https://www.jto.org/article/S1556-0864(16)32480-7/fulltext

U2 - 10.1016/J.JTHO.2016.11.1239

DO - 10.1016/J.JTHO.2016.11.1239

M3 - Article

VL - 12

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 1

ER -

P2.03a-030 nab-Paclitaxel/Carboplatin Induction Therapy in Squamous (SCC) NSCLC: Interim Quality of Life (QoL) Results From ABOUND.sqm: Topic: Clinical Trials

Disciplines

Access to Document

Other files and links

Cite this